Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD

被引:51
作者
Agatonovic-Kustrin, S [1 ]
Rades, T
Wu, V
Saville, D
Tucker, IG
机构
[1] Univ Sains Malaysia, Sch Pharmaceut Sci, Penang 11800, Malaysia
[2] Univ Otago, Sch Pharm, Dunedin, New Zealand
关键词
crystal; polymorphs; ranitidine;
D O I
10.1016/S0731-7085(01)00375-2
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The identification. characterization and quantification of crystal forms are becoming increasingly important within the pharmaceutical industry. A combination of different physical analytical techniques is usually necessary for this task. In this work solid-state techniques, diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) and X-ray powder diffractometry (XRPD) were combined to analyze polymorphic purity of crystalline ranitidine-HCl. an antiulcer drug, H2 receptor antagonists. A series of 12 different mixtures of Form 1 and 2 was prepared by geometric mixing and their DRIFT spectra and XRD powder patterns were obtained and analyzed, either alone or combined together, using Artificial Neural Networks (ANNs). A standard feed-forward network. with back-propagation rule and with multi layer preceptron architecture (MPL) was chosen. A working range of 1.0-100%: (w/w) of crystal Form 2 in Form 1 was established with a minimum quantifiable level (MQL) of 5.2% and limit of detection of 1.5% (w/w). The results demonstrate that DRIFTS combined with XRPD may be successfully used to distinguish between the ranitidine HCl polymorphs and to quantify the composition of binary mixtures of the two. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:741 / 750
页数:10
相关论文
共 38 条
[1]  
AGATONOVICKUSTR.S, 1999, PHARMACEUT RES, V16, P1479
[2]   Classification and quantitation of 1H NMR spectra of alditols binary mixtures using artificial neural networks [J].
Amendolia, SR ;
Doppiu, A ;
Ganadu, ML ;
Lubinu, G .
ANALYTICAL CHEMISTRY, 1998, 70 (07) :1249-1254
[3]  
[Anonymous], NZ PHARM
[4]   PSEUDOPOLYMORPHISM AND PHASE-STABILITY IN 4 SOLID FORMS OF (6R,7R)-7-[2-(5-AMINO-1,2,4-THIADIAZOL-3-YL)-(Z)-2-METHOXY-IMINOACETAMID]-3-[(4-CARBAMOYL-1-QUINUCLIDINIO)METHYL]-8-OXO-5-THIA-1-AZABICYCLO-[4,2,0]OCT-2-ENE-2-CARBOXYLATE (E1040) [J].
ASHIZAWA, K ;
UCHIKAWA, K ;
HATTORI, T ;
ISHIBASHI, Y ;
SATO, T ;
MIYAKE, Y .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1989, 78 (11) :893-899
[5]  
Bawazir SA, 1998, INT J CLIN PHARM TH, V36, P270
[6]  
BORKA L, 1991, PHARM ACTA HELV, V66, P16
[7]   COMPARISON OF THE TRAINING OF NEURAL NETWORKS FOR QUANTITATIVE X-RAY-FLUORESCENCE SPECTROMETRY BY A GENETIC ALGORITHM AND BACKWARD ERROR PROPAGATION [J].
BOS, M ;
WEBER, HT .
ANALYTICA CHIMICA ACTA, 1991, 247 (01) :97-105
[8]   PHARMACEUTICAL SOLIDS - A STRATEGIC APPROACH TO REGULATORY CONSIDERATIONS [J].
BYRN, S ;
PFEIFFER, R ;
GANEY, M ;
HOIBERG, C ;
POOCHIKIAN, G .
PHARMACEUTICAL RESEARCH, 1995, 12 (07) :945-954
[9]  
BYRN SR, 1982, SOLID STATE CHEM DRU, P7
[10]   ISOENERGETIC POLYMORPHS [J].
CARSTENSEN, JT ;
FRANCHINI, MK .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1995, 21 (05) :523-536